Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease.


Journal

Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250

Informations de publication

Date de publication:
08 2019
Historique:
received: 25 02 2019
revised: 03 06 2019
accepted: 27 06 2019
pubmed: 10 7 2019
medline: 9 9 2020
entrez: 9 7 2019
Statut: ppublish

Résumé

Given the increasing recognition of the significance of non-motor symptoms in Parkinson's disease, we investigate the optimal use of machine learning methods for the prediction of the Montreal Cognitive Assessment (MoCA) score at year 4 from longitudinal data obtained at years 0 and 1. We selected n = 184 PD subjects from the Parkinson's Progressive Marker Initiative (PPMI) database (93 features). A range of robust predictor algorithms (accompanied with automated machine learning hyperparameter tuning) and feature subset selector algorithms (FSSAs) were selected. We utilized 65%, 5% and 30% of patients in each arrangement for training, training validation and final testing respectively (10 randomized arrangements). For further testing, we enrolled 308 additional patients. First, we employed 10 predictor algorithms, provided with all 93 features; an error of 1.83 ± 0.13 was obtained by LASSOLAR (Least Absolute Shrinkage and Selection Operator - Least Angle Regression). Subsequently, we used feature subset selection followed by predictor algorithms. GA (Genetic Algorithm) selected 18 features; subsequently LOLIMOT (Local Linear Model Trees) reached an error of 1.70 ± 0.10. DE (Differential evolution) also selected 18 features and coupled with Thiel-Sen regression arrived at a similar performance. NSGAII (Non-dominated sorting genetic algorithm) yielded the best performance: it selected six vital features, which combined with LOLIMOT reached an error of 1.68 ± 0.12. Finally, using this last approach on independent test data, we reached an error of 1.65. By employing appropriate optimization tools (including automated hyperparameter tuning), it is possible to improve prediction of cognitive outcome. Overall, we conclude that optimal utilization of FSSAs and predictor algorithms can produce very good prediction of cognitive outcome in PD patients.

Sections du résumé

BACKGROUND
Given the increasing recognition of the significance of non-motor symptoms in Parkinson's disease, we investigate the optimal use of machine learning methods for the prediction of the Montreal Cognitive Assessment (MoCA) score at year 4 from longitudinal data obtained at years 0 and 1.
METHODS
We selected n = 184 PD subjects from the Parkinson's Progressive Marker Initiative (PPMI) database (93 features). A range of robust predictor algorithms (accompanied with automated machine learning hyperparameter tuning) and feature subset selector algorithms (FSSAs) were selected. We utilized 65%, 5% and 30% of patients in each arrangement for training, training validation and final testing respectively (10 randomized arrangements). For further testing, we enrolled 308 additional patients.
RESULTS
First, we employed 10 predictor algorithms, provided with all 93 features; an error of 1.83 ± 0.13 was obtained by LASSOLAR (Least Absolute Shrinkage and Selection Operator - Least Angle Regression). Subsequently, we used feature subset selection followed by predictor algorithms. GA (Genetic Algorithm) selected 18 features; subsequently LOLIMOT (Local Linear Model Trees) reached an error of 1.70 ± 0.10. DE (Differential evolution) also selected 18 features and coupled with Thiel-Sen regression arrived at a similar performance. NSGAII (Non-dominated sorting genetic algorithm) yielded the best performance: it selected six vital features, which combined with LOLIMOT reached an error of 1.68 ± 0.12. Finally, using this last approach on independent test data, we reached an error of 1.65.
CONCLUSION
By employing appropriate optimization tools (including automated hyperparameter tuning), it is possible to improve prediction of cognitive outcome. Overall, we conclude that optimal utilization of FSSAs and predictor algorithms can produce very good prediction of cognitive outcome in PD patients.

Identifiants

pubmed: 31284154
pii: S0010-4825(19)30216-1
doi: 10.1016/j.compbiomed.2019.103347
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

103347

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Mohammad R Salmanpour (MR)

Department of Energy Engineering and Physics, Amirkabir University of Technology, Tehran, Iran.

Mojtaba Shamsaei (M)

Department of Energy Engineering and Physics, Amirkabir University of Technology, Tehran, Iran.

Abdollah Saberi (A)

Department of Computer Engineering, Islamic Azad University, Tehran, Iran.

Saeed Setayeshi (S)

Department of Energy Engineering and Physics, Amirkabir University of Technology, Tehran, Iran.

Ivan S Klyuzhin (IS)

Department of Medicine, University of British Columbia, Vancouver, BC, Canada.

Vesna Sossi (V)

Department of Physics & Astronomy, University of British Columbia, Vancouver, BC, Canada.

Arman Rahmim (A)

Department of Radiology, University of British Columbia, Vancouver, BC, Canada; Department of Physics & Astronomy, University of British Columbia, Vancouver, BC, Canada; Department of Radiology, Johns Hopkins University, Baltimore, MD, USA. Electronic address: arman.rahmim@ubc.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH